3 news items
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
PRFX
31 May 24
experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct
PainReform Announces Closing of $4 Million Public Offering
PRFX
18 Apr 24
and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact
PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
PRFX
9 Apr 24
trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials
- Prev
- 1
- Next